Company / Cash per Share
Beta Bionics, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.74
FY2025
5-year range
$4.74 / $5.74
FY2023-FY2025
Trend
-17.5%
vs FY2024
Sector context
#52 of 146
Health Care
What the data says
At $4.74, Beta Bionics, Inc.'s cash per share ranks #52 of 146 in the Health Care sector. Declined from $5.01 to $4.74 over the past 2 years.
Based on SEC 10-K filings.
4.74 in FY2025.
Declined from $5.01 to $4.74 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#52 of 146 in Health CareTop 36% of 146This company $4.74 Sector average $27.73
▼
-82.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 17.5% year-over-year.
- Ranks #52 out of 146 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.74 | -17.5% |
| FY2024 | $5.74 | +14.6% |
| FY2023 | $5.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026